Intrinsic Value
Xilio Therapeutics, Inc. (XLO)
$1.28
+0.05 (+4.07%)
Enterprise Value | - |
---|---|
Net Debt | -32.15 |
Equity Value | - |
Shares Outstanding | 27.50 |
Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt